Clinical Trial Update: Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China

View source ↗

Summary

A clinical trial update examining the safety and efficacy of using postoperative denosumab for Giant Cell Tumor of Bone in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Giant Cell Tumor of Bone | Status: UNKNOWN